OnCore Login

Return to Trial Database

HCRN-GI99-1

A Phase II Study of Gemcitabine and Docetaxel in Combination for Advanced Pancreatic Cancer

Status

Study Completed

Cancer Type(s)

Pancreatic

Study Contact

Publications

Phase II study of gemcitabine and docetaxel in combination for advanced pancreatic cancer
  • BP Schneider, KN Ganjoo, LH Einhorn, J Picus, F Fata, PJ Loehrer, C Stoner

Trial Locations

All sites in which the trial HCRN-GI99-1 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278